Endoscopic Sinus Surgery (FESS) Success Rate in Mumbai
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
Endoscopic Sinus Surgery (FESS) Success Rate in Mumbai
Understanding the potential outcomes of Endoscopic Sinus Surgery (FESS) is crucial for patients. The `Endoscopic Sinus Surgery (FESS) success rate in Mumbai` provides essential insights for making confident healthcare decisions. This rate significantly depends on the specific sinus condition, the patient's overall health profile, and the surgical techniques employed. Mumbai, a major medical hub, offers comprehensive data and advanced facilities for FESS.
Outcomes for Endoscopic Sinus Surgery (FESS) in Mumbai are continuously evaluated using aggregated clinical data and patient follow-up. These statistics offer a clear overview of overall efficacy. While promising, individual results can vary based on factors like disease severity, pre-existing conditions, and adherence to post-operative care, influencing the `Endoscopic Sinus Surgery (FESS) recovery rate in Mumbai`.
Understanding Endoscopic Sinus Surgery (FESS) Success
For Endoscopic Sinus Surgery (FESS), "success" primarily signifies a notable improvement in chronic sinusitis symptoms, such as nasal congestion, facial pressure, and drainage. This often leads to a significant enhancement in the patient's overall quality of life. Success also involves reducing the frequency and severity of recurrent infections. Short-term success is immediate symptom relief, while long-term success reflects sustained improvement and minimal need for further interventions.
For patients in Mumbai undergoing FESS, understanding the potential for long-term symptom relief and disease control is paramount. The `Endoscopic Sinus Surgery (FESS) survival rate in Mumbai`, in this context, refers to the duration patients maintain a healthy, symptom-reduced state, minimizing the need for subsequent interventions. This emphasizes sustained well-being rather than direct survival from a life-threatening condition.
Endoscopic Sinus Surgery (FESS) Outcomes in Mumbai
Success rates vary depending on treatment approach and patient factors.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Chronic Rhinosinusitis (CRS) without Polyps | Persistent sinus inflammation, unresponsive to medication | 85%–95% | Significant symptom relief, reduced infection frequency |
| Chronic Rhinosinusitis (CRS) with Polyps | Nasal polyps causing obstruction and inflammation | 70%–85% | Polyp removal, improved breathing, often requires ongoing medical therapy |
| Fungal Sinusitis (Non-invasive) | Removal of fungal debris obstructing sinuses | 90%–95% | Complete fungal clearance, prevention of recurrence |
| Revision FESS | Previous FESS with recurrent or persistent symptoms | 60%–80% | Improvement in symptoms, less predictable than primary surgery |
Endoscopic Sinus Surgery (FESS) Survival Rate by Age in Mumbai
While traditional "staging" does not apply to sinusitis, the severity and extent of the condition, alongside patient demographics, can significantly influence sustained outcomes. The `stage wise Endoscopic Sinus Surgery (FESS) survival rate in Mumbai` can vary, reflecting how comprehensive initial disease management impacts long-term remission. Age-related factors also play a crucial role in recovery and long-term health maintenance.
| Age Group / Patient Category | Typical Considerations for FESS | Success Rate Range (%) |
|---|---|---|
| Pediatric Patients (Children) | Adenoid hypertrophy, chronic sinusitis, often less complex | 80%–90% |
| Adults (18-60 years) | Chronic Rhinosinusitis, polyps, fungal sinusitis | 85%–95% |
| Geriatric Patients (>60 years) | Co-morbidities, slower healing, potential medication interactions | 75%–85% |
Mumbai's Endoscopic Sinus Surgery (FESS) Success Rate: A Global View
Success rates for Endoscopic Sinus Surgery (FESS) in Mumbai are often comparable with international standards. This holds true particularly when similar advanced protocols, surgical technology, and rigorous patient selection criteria are meticulously applied. Leading centers follow evidence-based protocols, ensuring outcomes align with global benchmarks for FESS.
| Country | Endoscopic Sinus Surgery (FESS) Success Rate Range (%) |
|---|---|
| India (Mumbai) | 80%–95% |
| United States | 85%–95% |
| United Kingdom | 80%–90% |
| Singapore | 85%–93% |
| Germany | 82%–92% |
| Australia | 83%–94% |
These success rates are indicative and can vary significantly based on patient condition, disease complexity, and specific treatment approaches. Individual outcomes are never guaranteed.
Factors Influencing Endoscopic Sinus Surgery (FESS) Outcomes
- Severity and extent of the underlying sinusitis condition
- Presence of co-existing conditions like asthma, allergies, or nasal polyps
- Patient's overall health status and immune system response
- Adherence to crucial post-operative care and prescribed medical management
- The specific surgical technique employed and the surgeon's experience level
- Smoking status and other lifestyle factors influencing healing
Data Sources for Endoscopic Sinus Surgery (FESS) Outcomes
- National and regional health registries tracking surgical outcomes
- Peer-reviewed medical journals and extensive clinical studies
- Aggregated data from multi-hospital FESS outcome analyses and audits
- Guidelines and reports published by relevant medical societies
Informed Choices for FESS Outcomes
Understanding Endoscopic Sinus Surgery (FESS) success rates empowers patients to make informed decisions. This crucial knowledge supports aligning healthcare choices with personal health goals and expected recovery pathways.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.
Artemis Hospital
Sector 51, Gurugram, Haryana, India
Lokmanya Hospitals
Not Specified
White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India
Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.